Ontology highlight
ABSTRACT:
SUBMITTER: Soyka M
PROVIDER: S-EPMC7808982 | biostudies-literature | 2021 Jan
REPOSITORIES: biostudies-literature
Soyka Michael M Rösner Susanne S
Der Nervenarzt 20210101 1
So far few medications are approved for prophylactic treatment of alcohol dependence relapse. Apart from disulfiram, which is no longer marketed in Germany, the opioid antagonists naltrexone, nalmefene and the putative glutamate antagonist acamprosate are approved. In some other countries, baclofen and gamma-hydroxybutyrate (GHB) are licensed. Possible other drugs of interest for prophylaxis of alcohol dependence relapse are vareniclin, gabapentin, and topiramate, but so far none of them have re ...[more]